|
C4ORF3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.22832863272515E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.97437638355314E-12 |
| Normal-vs-Stage2 |
2.222300E-04 |
| Normal-vs-Stage3 |
1.61919999630555E-08 |
| Normal-vs-Stage4 |
4.11029987823497E-10 |
| Stage1-vs-Stage2 |
5.372600E-01 |
| Stage1-vs-Stage3 |
3.294200E-01 |
| Stage1-vs-Stage4 |
1.719970E-02 |
| Stage2-vs-Stage3 |
1.773550E-01 |
| Stage2-vs-Stage4 |
2.516400E-02 |
| Stage3-vs-Stage4 |
3.261800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.09456887997794E-12 |
| Normal-vs-AfricanAmerican |
2.03709999979651E-08 |
| Normal-vs-Asian |
4.673600E-02 |
| Caucasian-vs-AfricanAmerican |
9.735800E-01 |
| Caucasian-vs-Asian |
4.878400E-01 |
| AfricanAmerican-vs-Asian |
5.727400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.31339383813156E-13 |
| Normal-vs-Female |
1.04670000444784E-08 |
| Male-vs-Female |
1.874190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.02100000255146E-08 |
| Normal-vs-Extreme_Weight |
3.02202707302968E-13 |
| Normal-vs-Obese |
8.63939997319818E-09 |
| Normal-vs-Extreme_Obese |
2.37329999999147E-05 |
| Normal_Weight-vs-Extreme_Weight |
9.107800E-01 |
| Normal_Weight-vs-Obese |
4.346400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.512200E-01 |
| Extreme_Weight-vs-Obese |
2.269000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.369800E-01 |
| Obese-vs-Extreme_Obese |
7.766000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.963960E-04 |
| Normal-vs-Age(41-60Yrs) |
2.10254036403512E-12 |
| Normal-vs-Age(61-80Yrs) |
4.8221426851569E-12 |
| Normal-vs-Age(81-100Yrs) |
4.84450000004522E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.346400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.897800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.888400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.493400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.655600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.245000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.27202717645514E-12 |
| Normal-VS-Type2 PRCC |
3.93640675611096E-12 |
| Normal-VS-KIRP CIMP |
3.65570000049331E-07 |
| Normal-VS-Unclassified PRCC |
9.61590029824322E-10 |
| Type1 PRCC-VS-Type2 PRCC |
2.374000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.415200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.074800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.850800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.971600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.613400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.94260002423152E-09 |
| Normal-vs-N1 |
1.24655841204913E-12 |
| Normal-vs-N2 |
1.995230E-03 |
| N0-vs-N1 |
1.365640E-01 |
| N0-vs-N2 |
8.082600E-01 |
| N1-vs-N2 |
2.383800E-01 |
|
|
